Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

374 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cancer risks from germline p53 mutations.
Frebourg T, Friend SH. Frebourg T, et al. J Clin Invest. 1992 Nov;90(5):1637-41. doi: 10.1172/JCI116034. J Clin Invest. 1992. PMID: 1430194 Free PMC article. Review. No abstract available.
A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families.
Calvete O, Martinez P, Garcia-Pavia P, Benitez-Buelga C, Paumard-Hernández B, Fernandez V, Dominguez F, Salas C, Romero-Laorden N, Garcia-Donas J, Carrillo J, Perona R, Triviño JC, Andrés R, Cano JM, Rivera B, Alonso-Pulpon L, Setien F, Esteller M, Rodriguez-Perales S, Bougeard G, Frebourg T, Urioste M, Blasco MA, Benítez J. Calvete O, et al. Among authors: frebourg t. Nat Commun. 2015 Sep 25;6:8383. doi: 10.1038/ncomms9383. Nat Commun. 2015. PMID: 26403419 Free PMC article.
[Germline mutations of the p53 gene].
Frebourg T. Frebourg T. Pathol Biol (Paris). 1997 Dec;45(10):845-51. Pathol Biol (Paris). 1997. PMID: 9769948 Review. French.
Equal transcription of wild-type and mutant p53 using bicistronic vectors results in the wild-type phenotype.
Frebourg T, Sadelain M, Ng YS, Kassel J, Friend SH. Frebourg T, et al. Cancer Res. 1994 Feb 15;54(4):878-81. Cancer Res. 1994. PMID: 8313374
Screening patients for heterozygous p53 mutations using a functional assay in yeast.
Ishioka C, Frebourg T, Yan YX, Vidal M, Friend SH, Schmidt S, Iggo R. Ishioka C, et al. Among authors: frebourg t. Nat Genet. 1993 Oct;5(2):124-9. doi: 10.1038/ng1093-124. Nat Genet. 1993. PMID: 8252037
Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome.
Frebourg T, Barbier N, Yan YX, Garber JE, Dreyfus M, Fraumeni J Jr, Li FP, Friend SH. Frebourg T, et al. Am J Hum Genet. 1995 Mar;56(3):608-15. Am J Hum Genet. 1995. PMID: 7887414 Free PMC article.
Overcoming complexities in genetic screening for cancer susceptibility.
Friend SH, Iggo R, Ishioka C, Fitzgerald M, Hoover I, O'Neill E, Frebourg T. Friend SH, et al. Among authors: frebourg t. Cold Spring Harb Symp Quant Biol. 1994;59:673-6. doi: 10.1101/sqb.1994.059.01.077. Cold Spring Harb Symp Quant Biol. 1994. PMID: 7587129 No abstract available.
Cancer risks from germ line tumor suppressor gene mutations.
Frebourg T, Malkin D, Friend S. Frebourg T, et al. Princess Takamatsu Symp. 1991;22:61-70. Princess Takamatsu Symp. 1991. PMID: 1844252 Review.
Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.
Frebourg T, Kassel J, Lam KT, Gryka MA, Barbier N, Andersen TI, Børresen AL, Friend SH. Frebourg T, et al. Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6413-7. doi: 10.1073/pnas.89.14.6413. Proc Natl Acad Sci U S A. 1992. PMID: 1631137 Free PMC article.
A functional screen for germ line p53 mutations based on transcriptional activation.
Frebourg T, Barbier N, Kassel J, Ng YS, Romero P, Friend SH. Frebourg T, et al. Cancer Res. 1992 Dec 15;52(24):6976-8. Cancer Res. 1992. PMID: 1458490
374 results
Jump to page